Literature DB >> 20447096

Resurgence of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation and outcomes.

Dipika V Patel1, Sandra Rayner, Charles N J McGhee.   

Abstract

PURPOSE: To investigate the presentation, clinical characteristics and outcomes of Acanthamoeba keratitis (AK) in Auckland, New Zealand over a 7-year period.
METHODS: Retrospective analysis of all cases of AK treated by the tertiary corneal service at Auckland City Hospital/ University of Auckland Department of Ophthalmology (August 2001 to May 2008). Data were collected regarding age, gender, contact lens history, presenting signs and symptoms, diagnosis at first presentation, time to final diagnosis, identifiable risk factors, presenting and final visual acuity, results of microbiological testing, medical treatment, surgical interventions, recurrence of disease and length of follow up. All photographs and in vivo confocal microscopy images were reviewed.
RESULTS: Twenty-five eyes of 25 patients were identified with a diagnosis of AK (mean age 40 +/- 13 years). Ninety-six per cent were contact lens wearers. Mean time to diagnosis was 41 +/- 49 days (range 0-181 days, median 21 days). Fourteen patients (56%) had been treated with topical corticosteroids prior to the diagnosis. Early diagnosis of AK (<21 days) was associated with significantly better final visual acuity and did not require any surgical intervention compared with those diagnosed at a later stage. Six patients, all in the late diagnosis group, required surgical intervention.
CONCLUSIONS: AK has become significantly more common in New Zealand in the current decade. This study highlights the fundamental importance of early diagnosis and appropriate management in ensuring favourable outcomes. Practitioners should maintain a clinical suspicion of AK, especially as 96% of the subjects in this study were contact lens wearers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447096     DOI: 10.1111/j.1442-9071.2009.02182.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  7 in total

1.  Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics.

Authors:  Prajna Lalitha; Charles C Lin; Muthiah Srinivasan; Jeena Mascarenhas; N Venkatesh Prajna; Jeremy D Keenan; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman; Travis C Porco
Journal:  Ophthalmic Epidemiol       Date:  2012-02-24       Impact factor: 1.648

Review 2.  Biology and pathogenesis of Acanthamoeba.

Authors:  Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Parasit Vectors       Date:  2012-01-10       Impact factor: 3.876

3.  Presumed late recurrence of Acanthamoeba keratitis exacerbated by exposure to topical corticosteroids.

Authors:  Dipika V Patel; Charles Nj McGhee
Journal:  Oman J Ophthalmol       Date:  2013-09

4.  Evaluation of Acanthamoeba keratitis cases in a tertiary medical care centre over 21 years.

Authors:  Wolfgang List; Wilfried Glatz; Regina Riedl; Georg Mossboeck; Gernot Steinwender; Andreas Wedrich
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

5.  Acanthamoeba Keratitis in Egypt: Characteristics and Treatment Outcomes.

Authors:  Mohamed H Nasef; Sharif Y El Emam; Mohamed S ElShorbagy; Waleed A Allam
Journal:  Clin Ophthalmol       Date:  2021-03-29

6.  In-vitro analysis of the microbicidal activity of 6 contact lens care solutions.

Authors:  Claudia Hildebrandt; Daniela Wagner; Thomas Kohlmann; Axel Kramer
Journal:  BMC Infect Dis       Date:  2012-10-03       Impact factor: 3.090

7.  Impression cytology in eyes with clinical and confocal scan features of acanthamoeba keratitis.

Authors:  Mozhgan Rezaei Kanavi; Bagher Hosseini; Fatemeh Javadi; Nasser Rakhshani; Mohammad-Ali Javadi
Journal:  J Ophthalmic Vis Res       Date:  2013-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.